Euro Vital Pharma GmbH
Pharmaceutical Companies · Hamburg
Euro Vital Pharma GmbH is a pharmaceutical company based in Hamburg, Hamburg, Germany. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Euro Vital Pharma GmbH Address & Contact
Euro Vital Pharma GmbH at a Glance
Euro Vital Pharma GmbH from Hamburg is a trading and distribution company specializing in the distribution of vitamins, dietary supplements, and pharmaceutical products. In the northern German market, the company plays an important role by supplying pharmacies, health food stores, and specialized retailers with a diverse range of health products. Founded with the goal of promoting consumer health, Euro Vital Pharma GmbH has established itself over the years as a trusted partner in the healthcare sector.
Services and Products
The portfolio of Euro Vital Pharma GmbH includes a wide range of products, including vitamins, minerals, antioxidants, and other dietary supplements. These products are aimed at various target groups, including athletes, seniors, and individuals with specific nutritional needs. In addition to dietary supplements, the company also distributes selected pharmaceuticals that are approved according to legal regulations. Euro Vital Pharma places great emphasis on product quality and uses only high-quality raw materials sourced in collaboration with renowned, certified manufacturers.
The products strictly comply with the regulatory requirements of the German and European markets, including the guidelines from the European Medicines Agency (EMA) and the Federal Institute for Drugs and Medical Devices (BfArM). This ensures that all items meet the highest standards in terms of safety and efficacy.
Location Hamburg
Hamburg, as one of Europe's leading trading centers, offers ideal conditions for Euro Vital Pharma GmbH with its excellent harbor logistics and economic infrastructure. The Hamburg metropolitan region has an extensive network of pharmacies and specialized retail partners, enabling prompt and efficient market supply. From here, not only regional markets are serviced but also national and international partnerships are promoted.
The location in Hamburg is not only strategically advantageous but also historically significant for the pharmaceutical and health industry. The city has a long tradition in pharmaceutical wholesale and is home to numerous companies and research institutions dealing with health issues. This creates a favorable environment for innovation and collaboration, which Euro Vital Pharma GmbH also benefits from.
Regulatory Classification
Euro Vital Pharma GmbH operates within a strictly regulated market. The products are subject to the requirements of the Medicines Act (AMG) as well as the regulations of the Food and Consumer Goods Ordinance (LFGB). Special attention is paid to compliance with Good Distribution Practice (GDP), which ensures that products remain safe and of high quality throughout the entire supply chain from production to end consumer. This strengthens consumer trust in the products offered.
Regional Importance and Special Features
Euro Vital Pharma GmbH not only plays an important economic role in the Hamburg region but is also actively committed to the health of the population. The company regularly offers training and information events for pharmacists and specialized retail partners to discuss the latest developments in health products. This not only enhances knowledge about the products but also raises awareness of the significance of prevention and a healthy lifestyle.
Another aspect that distinguishes Euro Vital Pharma GmbH is its close cooperation with local health initiatives and organizations. These collaborations aim to dispel misunderstandings about dietary supplements and to provide well-founded knowledge about their benefits and applications. In this context, the company also conducts research projects and participates in scientific studies to further improve the effectiveness of its products.
Other pharmaceutical companies: Pharmaceutical Companies Overview | Pharmaceutical Companies Hamburg | Pharmaceutical Wholesale
Frequently asked questions about Euro Vital Pharma GmbH
What does Euro Vital Pharma GmbH do?
Euro Vital Pharma GmbH is a pharmaceutical company based in Hamburg that develops, manufactures or distributes pharmaceutical products. The company is active in the German healthcare market.
Where is Euro Vital Pharma GmbH located?
Euro Vital Pharma GmbH is headquartered in Hamburg, Germany. More information can be found on the company's website.
What products does Euro Vital Pharma GmbH distribute?
Euro Vital Pharma GmbH is active in the pharmaceutical sector. Detailed information on the products offered and therapeutic areas can be found on the company's website or via the contact details provided.
Euro Vital Pharma GmbH on social media
More Pharmaceutical Companies in Hamburg
Pharmaceutical Companies in Germany
Related areas in healthcare
Pharmaceutical Companies by location
About Pharmaceutical Companies
Germany is one of the world's leading pharmaceutical nations, home to more than 1,000 pharmaceutical businesses employing approximately 130,000 people (vfa 2023). Companies operating in this sector develop, manufacture and distribute medicines across the entire value chain, from early-stage research and clinical trials through to market authorisation and commercial distribution. In Germany, every manufacturer of medicinal products must hold a manufacturing authorisation (Herstellungserlaubnis) issued under Section 13 of the AMG (Arzneimittelgesetz, Germany's Medicinal Products Act). Medicines may only be placed on the market after receiving approval from either BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte, Germany's Federal Institute for Drugs and Medical Devices, broadly comparable to the FDA in the United States or the MHRA in the United Kingdom) or the European Medicines Agency (EMA) via the centralised procedure. All manufacturing sites are subject to regular GMP (Good Manufacturing Practice) inspections carried out by the competent pharmaceutical supervisory authority of the relevant German federal state. The sector covers prescription-only medicines (Rx), non-prescription OTC products, generics, biosimilars and active pharmaceutical ingredients (APIs). This directory lists pharmaceutical manufacturers, marketers and licence holders across all German federal states with full contact details, addresses and phone numbers.
Germany's Pharmaceutical Industry
Germany is consistently ranked among the top five pharmaceutical markets worldwide, generating annual revenues exceeding EUR 50 billion and accounting for the largest share of pharmaceutical production in continental Europe. The industry is represented by two major associations: vfa (Verband Forschender Arzneimittelhersteller), which represents research-based companies, and BAH (Bundesverband der Arzneimittel-Hersteller), which represents the broader manufacturer base including OTC and self-medication products. German pharmaceutical companies cover the full spectrum from global innovator corporations and mid-sized specialty manufacturers to generic producers and biotech firms. The country is a world leader in active pharmaceutical ingredient (API) production, biologics manufacturing and pharmaceutical chemistry. Key therapeutic areas of strength include oncology, cardiovascular medicine, immunology, neuroscience and rare diseases. Germany also serves as a significant export hub, with pharmaceutical products among the country's leading export categories. The sector benefits from a highly skilled workforce, world-class university research institutions and a dense network of research hospitals (Universitätsklinika) that facilitate clinical trial activity.
Regulatory Framework: BfArM, EMA and the AMG
The legal foundation for pharmaceutical activity in Germany is the Arzneimittelgesetz (AMG, German Medicinal Products Act), which regulates the authorisation, manufacture, import, distribution, labelling and pharmacovigilance of medicinal products. For English-speaking readers unfamiliar with the German regulatory landscape: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) is the national competent authority responsible for approving medicines marketed only in Germany, supervising narcotics, and maintaining the pharmacovigilance database. BfArM is a higher federal authority (Bundesoberbehörde) subordinate to the Federal Ministry of Health (Bundesministerium für Gesundheit). For medicines approved via the centralised EU procedure, the European Medicines Agency (EMA) grants a single marketing authorisation valid in all 27 EU member states. Germany is also home to the Paul-Ehrlich-Institut (PEI), a second federal authority that specifically handles biological medicines including vaccines, blood products and gene therapy products. Manufacturing sites are inspected by state-level pharmaceutical supervisory authorities (Landesbehörden) to verify GMP compliance, with findings entered into the EudraGMDP database operated by the EMA.
Regional Pharmaceutical Clusters in Germany
Germany's pharmaceutical industry is geographically distributed across several major regional clusters. The Rhine-Main area around Frankfurt and Leverkusen in North Rhine-Westphalia is home to some of Germany's largest pharmaceutical sites, including facilities belonging to global corporations with long histories in German chemistry and pharmaceuticals. Bavaria (particularly Munich, Penzberg and Marburg) is a second major hub, especially strong in biotechnology and biologics production. Baden-Württemberg, including cities such as Mannheim, Heidelberg and Biberach an der Riss, is home to several significant research-based manufacturers. Hamburg and the northern German region have a cluster of specialty and generic manufacturers. Berlin has a growing biotech scene connected to its research universities and the Charité hospital. Hesse is notable for its proximity to Frankfurt's logistics infrastructure and several major API manufacturers. Smaller but significant clusters exist in Saxony (Leipzig, Dresden) and Lower Saxony, benefiting from proximity to university research centres and historically established chemical industry sites.
Drug Classes and Product Segments
German pharmaceutical companies cover all major drug classes. Prescription (Rx) products account for the largest share of revenue; generics manufacturers such as Stada, ratiopharm (Teva) and Hexal produce chemically equivalent alternatives after patent expiry, significantly reducing costs for the healthcare system. Biologics and biosimilars are gaining ground rapidly: monoclonal antibodies, insulin analogues and recombinant growth factors require specialised biotech manufacturing facilities. OTC products (over-the-counter), i.e. medicines available without a prescription, represent a multi-billion-euro market served by companies such as Bayer Consumer Health, Stada and Klosterfrau. Homeopathic preparations, herbal medicines and dietary supplements form further regulated segments. Digitalisation is increasingly shaping the sector: Digital Health Applications (DiGA) have been reimbursable since 2020, and AI-assisted drug development is significantly shortening time-to-market.
What does a pharmaceutical company do?
Pharmaceutical companies develop, produce and distribute medicines. They cover the entire value chain from research and clinical trials through to market launch and distribution. In Germany, they are supervised by BfArM (the Federal Institute for Drugs and Medical Devices, comparable to the FDA or MHRA).
How are pharmaceutical companies regulated in Germany?
Pharmaceutical companies in Germany must hold a manufacturing authorisation under Section 13 of the AMG (German Medicinal Products Act). All authorised medicines require approval from either BfArM or the European Medicines Agency (EMA). Regular GMP (Good Manufacturing Practice) inspections ensure quality standards are maintained.
Where can I find contact details for pharmaceutical companies in Germany?
Industry associations such as vfa (Association of Research-Based Pharmaceutical Companies) and BPI (Federal Association of the German Pharmaceutical Industry) maintain member directories. Many companies also list their key contacts directly on their websites. Sanoliste provides a searchable directory of pharmaceutical companies in Germany sorted by federal state and city.
How many pharmaceutical companies are there in Germany?
Germany is home to more than 1,000 pharmaceutical companies employing approximately 130,000 people, according to vfa (the Association of Research-Based Pharmaceutical Companies) 2023 data. The sector includes multinational corporations, mid-sized specialty firms, generic manufacturers and biotech startups.
What is BfArM and what does it regulate?
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) is Germany's Federal Institute for Drugs and Medical Devices. It is a higher federal authority within the portfolio of the Federal Ministry of Health and is responsible for approving medicines for the German market, monitoring drug safety (pharmacovigilance), regulating narcotics and controlled substances, and overseeing medical devices in Germany. It is broadly comparable to the FDA in the United States or the MHRA in the United Kingdom.
What is the difference between BfArM approval and EMA approval?
Medicines in Germany can be approved through two main routes. BfArM grants national marketing authorisations valid in Germany, or decentralised and mutual recognition procedure approvals valid in multiple EU states. The EMA (European Medicines Agency) grants centralised marketing authorisations valid in all 27 EU member states simultaneously, typically used for innovative biologic medicines, oncology drugs and products for rare diseases.
What does GMP mean in the context of German pharmaceutical manufacturing?
GMP stands for Good Manufacturing Practice. In Germany and the EU, GMP compliance is a legal requirement for all pharmaceutical manufacturers under the AMG and the EU GMP Guidelines (EudraLex Volume 4). GMP covers all aspects of production including premises, equipment, personnel qualification, process validation, documentation and quality control. Compliance is verified by regular inspections from the competent state pharmaceutical supervisory authority.